These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36790438)

  • 1. Autoantibodies Drive Heart Damage Caused by Concomitant Radiation and PD-1 Blockade.
    Yan B; Hooper DC; Yuan Z; Wang C; Chen Y; Lu B
    Cancer Immunol Res; 2023 Apr; 11(4):546-555. PubMed ID: 36790438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-1 Modulates Radiation-Induced Cardiac Toxicity through Cytotoxic T Lymphocytes.
    Du S; Zhou L; Alexander GS; Park K; Yang L; Wang N; Zaorsky NG; Ma X; Wang Y; Dicker AP; Lu B
    J Thorac Oncol; 2018 Apr; 13(4):510-520. PubMed ID: 29247829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients.
    Sarocchi M; Grossi F; Arboscello E; Bellodi A; Genova C; Dal Bello MG; Rijavec E; Barletta G; Rossi G; Biello F; Ghigliotti G; Canepa M; Mussap M; Brunelli C; Spallarossa P
    Oncologist; 2018 Aug; 23(8):936-942. PubMed ID: 29567824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non-Small-Cell Lung Cancer.
    Dess RT; Sun Y; Matuszak MM; Sun G; Soni PD; Bazzi L; Murthy VL; Hearn JWD; Kong FM; Kalemkerian GP; Hayman JA; Ten Haken RK; Lawrence TS; Schipper MJ; Jolly S
    J Clin Oncol; 2017 May; 35(13):1395-1402. PubMed ID: 28301264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Radiotherapy and Anti-PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non-Small Cell Lung Cancer.
    Gong X; Li X; Jiang T; Xie H; Zhu Z; Zhou F; Zhou C
    J Thorac Oncol; 2017 Jul; 12(7):1085-1097. PubMed ID: 28478231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of immune checkpoint inhibitor-induced cardiotoxicity reveals interleukin-17A as a driver of cardiac dysfunction after anti-PD-1 treatment.
    Gergely TG; Kucsera D; Tóth VE; Kovács T; Sayour NV; Drobni ZD; Ruppert M; Petrovich B; Ágg B; Onódi Z; Fekete N; Pállinger É; Buzás EI; Yousif LI; Meijers WC; Radovits T; Merkely B; Ferdinandy P; Varga ZV
    Br J Pharmacol; 2023 Mar; 180(6):740-761. PubMed ID: 36356191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
    Bustová I
    Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration in tumoural PD-L1 expression and stromal CD8-positive tumour-infiltrating lymphocytes after concurrent chemo-radiotherapy for non-small cell lung cancer.
    Yoneda K; Kuwata T; Kanayama M; Mori M; Kawanami T; Yatera K; Ohguri T; Hisaoka M; Nakayama T; Tanaka F
    Br J Cancer; 2019 Sep; 121(6):490-496. PubMed ID: 31388183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Mouse Model of Radiation-Induced Cardiac Injury Reveals Biological and Radiological Biomarkers of Cardiac Dysfunction with Potential Clinical Relevance.
    Dreyfuss AD; Goia D; Shoniyozov K; Shewale SV; Velalopoulou A; Mazzoni S; Avgousti H; Metzler SD; Bravo PE; Feigenberg SJ; Ky B; Verginadis II; Koumenis C
    Clin Cancer Res; 2021 Apr; 27(8):2266-2276. PubMed ID: 33542079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined application of bevacizumab and PD-1 blockade displays durable treatment effects by increasing the infiltration and cytotoxic function of CD8
    Liu Y; Zhang T; Zhang L; Zhao C; Zhang Z; Wang Z; Gu M; Li W; Li B
    Immunotherapy; 2022 Jun; 14(9):695-708. PubMed ID: 35574588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal assessment of acute cardiac toxicity induced by thoracic radiotherapy in cancer patients. Study protocol.
    Merino T; Pinto MP; Orellana MP; Martinez G; Andía M; Munoz-Schuffenegger P; Acevedo F; Gabrielli L; Sanchez C; Pereira J
    BMC Cancer; 2021 Oct; 21(1):1114. PubMed ID: 34663256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between circulating tumor-associated autoantibodies and clinical outcomes in advanced-stage NSCLC patients receiving PD-1/-L1 directed immune checkpoint inhibition.
    Tarhoni I; Wakefield CJ; Kollipara R; Fidler MJ; Batus M; Bonomi P; Borgia JA
    J Immunol Methods; 2021 Mar; 490():112956. PubMed ID: 33434603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trastuzumab aggravates radiation induced cardiotoxicity in mice.
    Yi P; Li H; Su J; Cai J; Xu C; Chen J; Cao L; Li M
    Am J Cancer Res; 2022; 12(1):381-395. PubMed ID: 35141025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-1 restrains IL-17A production from γδ T cells to modulate acute radiation-induced lung injury.
    Sheng Y; Chen K; Jiang W; Wu Z; Zhang W; Jing H; Wang L; Qu C; Ren H
    Transl Lung Cancer Res; 2021 Feb; 10(2):685-698. PubMed ID: 33718014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmed Cell Death-1: Programmed Cell Death-Ligand 1 Interaction Protects Human Cardiomyocytes Against T-Cell Mediated Inflammation and Apoptosis Response In Vitro.
    Tay WT; Fang YH; Beh ST; Liu YW; Hsu LW; Yen CJ; Liu PY
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 17. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
    Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
    J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCF-1
    Fang X; Wu G; Hua J; Zhao P; Shan M; Wang N; Zeng Y; Ding T; Zhu H; Zhu X; Zhang L; Liu Y; Zheng L; Yi X; Gao S
    J Cancer Res Clin Oncol; 2022 Oct; 148(10):2653-2660. PubMed ID: 34725738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1 blockade-unresponsive human tumor-infiltrating CD8
    Kim KH; Kim HK; Kim HD; Kim CG; Lee H; Han JW; Choi SJ; Jeong S; Jeon M; Kim H; Koh J; Ku BM; Park SH; Ahn MJ; Shin EC
    Cell Mol Immunol; 2021 Feb; 18(2):385-397. PubMed ID: 32332901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer.
    Kim CG; Kim G; Kim KH; Park S; Shin S; Yeo D; Shim HS; Yoon HI; Park SY; Ha SJ; Kim HR
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34907028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.